Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
US7931900B2 · kind B2 · utility
4Cited by
35References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2008 |
| Grant date | Apr 26, 2011 |
| Priority date | — |
| Expiry date | Nov 24, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for the treatment and/or prophylaxis of multiple sclerosis (MS) comprising administering a therapeutically effective amount of an inhibitor of IL-17 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.